home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  March 20, 2018
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 581 active entries

Evitra AB

Box 23052
104 35 Stockholm

Phone: +46 8 524 868 72
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.


Evitra is a Swedish biotech company that offers a solution to the problem of obtaining soluble protein expression also for mammalian proteins in Escherichia coli. Evitra launches the SPOTLIGHT system that constitutes a major technological breakthrough and enables soluble protein production within weeks at dramatically improved success rates. Evitra offers SPOTLIGHT either as a service or as a technology transfer license agreement to pharmaceutical and biotech companies.

Selected Categories:

Product Company   Service Company
- Research
- Research
- Services

Last update of this entry: October 08, 2012

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.